Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 in the page footer. No other visible changes to the study details or page layout.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded 'Multiple myeloma' and related topics (MedlinePlus Genetics). Included a note that publications are automatically filled from PubMed and updated the revision tag to v3.3.1.SummaryDifference0.2%

- Check29 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operating status from the page, which previously informed users about potential delays and the center's operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedDeleted the 'Multiple myeloma' topic and its related 'MedlinePlus Genetics' link from the Related Topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check50 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics' to the page's related topics section. These additions are metadata that help with discoverability and navigation rather than altering core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a MedlinePlus Genetics topic on multiple myeloma and a new Blood journal article citation related to circulating tumor cells and myeloma outcomes; no deletions were found.SummaryDifference2%

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.